Effect of the Association of Neurokinin-1 Receptor Antagonist Aprepitant to Dexamethasone/Ondansetron in the Incidence of Postoperative Nausea and Vomiting in High Risk Apfel Score Patients

Trial Profile

Effect of the Association of Neurokinin-1 Receptor Antagonist Aprepitant to Dexamethasone/Ondansetron in the Incidence of Postoperative Nausea and Vomiting in High Risk Apfel Score Patients

Completed
Phase of Trial: Phase IV

Latest Information Update: 07 Jan 2018

At a glance

  • Drugs Aprepitant (Primary) ; Dexamethasone; Ondansetron
  • Indications Postoperative nausea and vomiting
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Jan 2018 Primary endpoint (Incidence of nausea and vomiting in postoperative period) has been met, according to the results published in the Acta Anaesthesiologica Scandinavica
    • 07 Jan 2018 Results published in the Acta Anaesthesiologica Scandinavica
    • 24 Aug 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top